NeuroCognitive Communicator: Safety Study

Clinical trial NCT03100110 · UNKNOWN

Trial details

NCT number: NCT03100110
Sponsor: Ottawa Hospital Research Institute
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Motor Neuron Disease, Amyotrophic Lateral Sclerosis Tetraplegia

Start date: 2019-05-13
Primary completion: 2024-04-15
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.